These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
200 related articles for article (PubMed ID: 31106974)
41. Genetic or pharmacologic blockade of enhancer of zeste homolog 2 inhibits the progression of peritoneal fibrosis. Shi Y; Tao M; Wang Y; Zang X; Ma X; Qiu A; Zhuang S; Liu N J Pathol; 2020 Jan; 250(1):79-94. PubMed ID: 31579944 [TBL] [Abstract][Full Text] [Related]
42. Inhibition of microRNA-448 suppresses CD4 Zhang J; Guo Y; Sun Y; Chang L; Wang X Biochem Biophys Res Commun; 2022 Mar; 596():88-96. PubMed ID: 35121374 [TBL] [Abstract][Full Text] [Related]
44. ALW peptide ameliorates lupus nephritis in MRL/lpr mice. Wang H; Lu M; Zhai S; Wu K; Peng L; Yang J; Xia Y Arthritis Res Ther; 2019 Dec; 21(1):261. PubMed ID: 31791413 [TBL] [Abstract][Full Text] [Related]
45. Remission of systemic lupus erythematosus disease activity with regulatory cytokine interleukin (IL)-35 in Murphy Roths Large (MRL)/lpr mice. Cai Z; Wong CK; Dong J; Chu M; Jiao D; Kam NW; Lam CW; Tam LS Clin Exp Immunol; 2015 Aug; 181(2):253-66. PubMed ID: 25845911 [TBL] [Abstract][Full Text] [Related]
46. Chemokine receptor Ccr2 deficiency reduces renal disease and prolongs survival in MRL/lpr lupus-prone mice. Pérez de Lema G; Maier H; Franz TJ; Escribese M; Chilla S; Segerer S; Camarasa N; Schmid H; Banas B; Kalaydjiev S; Busch DH; Pfeffer K; Mampaso F; Schlöndorff D; Luckow B J Am Soc Nephrol; 2005 Dec; 16(12):3592-601. PubMed ID: 16267157 [TBL] [Abstract][Full Text] [Related]
47. EGR2 is elevated and positively regulates inflammatory IFNγ production in lupus CD4 Dai R; Heid B; Xu X; Xie H; Reilly CM; Ahmed SA BMC Immunol; 2020 Jul; 21(1):41. PubMed ID: 32646370 [TBL] [Abstract][Full Text] [Related]
48. EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice. Wu L; Jiang X; Qi C; Zhang C; Qu B; Shen N Front Immunol; 2021; 12():653989. PubMed ID: 33868295 [TBL] [Abstract][Full Text] [Related]
49. Inhibition of receptor interacting protein kinase-1 (RIPK1) in the treatment of murine lupus. Peng L; Wang P; Xu X; Chen D; Xu F; Yang F; Yang S; Xia H; Liu ZH; Qin W Lupus Sci Med; 2024 Jun; 11(1):. PubMed ID: 38906550 [TBL] [Abstract][Full Text] [Related]
50. Celastrol ameliorates lupus by promoting apoptosis of autoimmune T cells and preventing autoimmune response in MRL/lpr mice. Xie T; Rui H; Liu H; Liu X; Liu X; Li P Lupus Sci Med; 2024 Mar; 11(1):. PubMed ID: 38471722 [TBL] [Abstract][Full Text] [Related]
51. Vaccination with autoreactive CD4(+)Th1 clones in lupus-prone MRL/Mp-Fas(lpr/lpr) mice. Fujii T; Okada M; Fujita Y; Sato T; Tanaka M; Usui T; Umehara H; Mimori T J Autoimmun; 2009 Sep; 33(2):125-34. PubMed ID: 19596182 [TBL] [Abstract][Full Text] [Related]
52. Tetra-arsenic tetra-sulfide ameliorates lupus syndromes by inhibiting IL-17 producing double negative T cells. Zhao Y; Mu Z; Cai L; Liu X; Jia J; Zhang J Dermatol Ther; 2019 Jul; 32(4):e12849. PubMed ID: 30707471 [TBL] [Abstract][Full Text] [Related]
55. Regulation of T cell-dependent autoantibody production by a gammadelta T cell line derived from lupus-prone mice. Fujii T; Okada M; Craft J Cell Immunol; 2002; 217(1-2):23-35. PubMed ID: 12425998 [TBL] [Abstract][Full Text] [Related]
56. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. Hou LF; He SJ; Li X; Yang Y; He PL; Zhou Y; Zhu FH; Yang YF; Li Y; Tang W; Zuo JP Arthritis Rheum; 2011 Aug; 63(8):2445-55. PubMed ID: 21484768 [TBL] [Abstract][Full Text] [Related]
57. Decreased expression of the Ets family transcription factor Fli-1 markedly prolongs survival and significantly reduces renal disease in MRL/lpr mice. Zhang XK; Gallant S; Molano I; Moussa OM; Ruiz P; Spyropoulos DD; Watson DK; Gilkeson G J Immunol; 2004 Nov; 173(10):6481-9. PubMed ID: 15528390 [TBL] [Abstract][Full Text] [Related]
58. [Effects of HS1-associated protein X-1 on the lupus activities: experiment with MRL/lpr lupus-like mice]. Zhai ZF; Zhou CL; Zhong BY; Ao JH; Hao F Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):406-10. PubMed ID: 18581896 [TBL] [Abstract][Full Text] [Related]
59. Histone H3K27 methyltransferase EZH2 and demethylase JMJD3 regulate hepatic stellate cells activation and liver fibrosis. Jiang Y; Xiang C; Zhong F; Zhang Y; Wang L; Zhao Y; Wang J; Ding C; Jin L; He F; Wang H Theranostics; 2021; 11(1):361-378. PubMed ID: 33391480 [No Abstract] [Full Text] [Related]
60. The fungal lactone oxacyclododecindione is a potential new therapeutic substance in the treatment of lupus-associated kidney disease. Henke J; Erkel G; Brochhausen C; Kleinert H; Schwarting A; Menke J; Pautz A Kidney Int; 2014 Oct; 86(4):780-9. PubMed ID: 24717299 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]